BioMed Central | Members | Istituti Fisioterapici Ospitalieri - Regina Elena National Cancer Institute JECCR

Submit a manuscript Register Contact us

Institution search

Search by institution name/city

Members

Australia (21)
Austria (6)
Belgium (3)
Brazil (4)
Burkina Faso (1)
Canada (25)
Central African Republic (1)
China (3)
Cyprus (3)
Czech Republic (1)
Denmark (2)
Ethiopia (1)
Finland (6)
France (7)
Germany (51)
Ghana (3)
Greece (1)
Hong Kong (2)
Hungary (1)
India (8)
Ireland (1)
Israel (1)
Italy (16)
Kenya (3)
Korea, South (2)
Lebanon (1)
Lithuania (2)
Luxembourg (1)
Madagascar (1)
Malaysia (4)
Mexico (1)
Morocco (2)
Netherlands (11)
New Zealand (1)
Nigeria (2)
Norway (4)
Poland (2)
Portugal (1)
Romania (1)
South Africa (6)
Spain (13)
Sri Lanka (2)
Sweden (9)
Switzerland (10)
Taiwan (3)
Tanzania (3)
Thailand (1)
Trinidad and Tobago (1)
Uganda (1)
United Kingdom (49)
United States of America (159)

Advertisement

Member - Istituti Fisioterapici Ospitalieri - Regina Elena National Cancer Institute JECCR

As a researcher or student at Regina Elena National Cancer Institute, you can publish an unlimited number of research articles in Journal of Experimental & Clinical Cancer Research without paying any article processing charges.

Work published with BioMed Central, Chemistry Central and SpringerOpen by researchers at Istituti Fisioterapici Ospitalieri - Regina Elena National Cancer Institute JECCR

Display/download options Articles per page: 25 | 50 | 100

Display options

Editor's summary Citation

Download options

Send
To

	1.	Research Magnitude of risks and benefits of the addition of bevacizumab to chemotherapy for advanced breast cancer patients: Meta-regression analysis of randomized trials Federica Cuppone, Emilio Bria, Vanja Vaccaro, Fabio Puglisi, Alessandra Fabi, Isabella Sperduti, Paolo Carlini, Michele Milella, Cecilia Nisticò, Michelangelo Russillo, Paola Papaldo, Gianluigi Ferretti, Matti Aapro, Diana Giannarelli, Francesco Cognetti Journal of Experimental & Clinical Cancer Research 2011, 30:54 (12 May 2011) Abstract \| Full text \| PDF \| PubMed \| Cited on BioMed Central
	2.	Research IsoBED: a tool for automatic calculation of biologically equivalent fractionation schedules in radiotherapy using IMRT with a simultaneous integrated boost (SIB) technique Vicente Bruzzaniti, Armando Abate, Massimo Pedrini, Marcello Benassi, Lidia Strigari Journal of Experimental & Clinical Cancer Research 2011, 30:52 (9 May 2011) Abstract \| Full text \| PDF \| PubMed \| Cited on BioMed Central
	3.	Review Maintenance therapy in NSCLC: why? To whom? Which agent? Silvia Novello, Michele Milella, Marcello Tiseo, Giuseppe Banna, Diego Cortinovis, Massimo Di Maio, Marina Garassino, Paolo Maione, Olga Martelli, Tiziana Vavalà, Emilio Bria Journal of Experimental & Clinical Cancer Research 2011, 30:50 (6 May 2011) Abstract \| Full text \| PDF \| PubMed
	4.	Review Down-regulation of UHRF1, associated with re-expression of tumor suppressor genes, is a common feature of natural compounds exhibiting anti-cancer properties Mahmoud Alhosin, Tanveer Sharif, Marc Mousli, Nelly Etienne-Selloum, Guy Fuhrmann, Valérie B Schini-Kerth, Christian Bronner Journal of Experimental & Clinical Cancer Research 2011, 30:41 (15 April 2011) Abstract \| Full text \| PDF \| PubMed \| Cited on BioMed Central
	5.	Research AIDS-Kaposi Sarcoma and Classic Kaposi Sarcoma: are different ultrasound patterns related to different variants? Francesco M Solivetti, Fulvia Elia, Alessandra Latini, Carlo Cota, Paola Cordiali-Fei, Aldo Di Carlo Journal of Experimental & Clinical Cancer Research 2011, 30:40 (13 April 2011) Abstract \| Full text \| PDF \| PubMed
	6.	Research A multicenter prospective phase II randomized trial of epirubicin/vinorelbine versus pegylated liposomal doxorubicin/vinorelbine as first-line treatment in advanced breast cancer. A GOIM study Patrizia Vici, Giuseppe Colucci, Francesco Giotta, Domenico Sergi, Gianfranco Filippelli, Pasquale Perri, Claudio Botti, Enrico Vizza, Armando Carpino, Laura Pizzuti, Agnese Latorre, Diana Giannarelli, Massimo Lopez, Luigi Di Lauro Journal of Experimental & Clinical Cancer Research 2011, 30:39 (12 April 2011) Abstract \| Full text \| PDF \| PubMed
	7.	Research Brain metastases from solid tumors: disease outcome according to type of treatment and therapeutic resources of the treating center Alessandra Fabi, Alessandra Felici, Giulio Metro, Alessandra Mirri, Emilio Bria, Stefano Telera, Luca Moscetti, Michelangelo Russillo, Gaetano Lanzetta, Giovanni Mansueto, Andrea Pace, Marta Maschio, Antonello Vidiri, Isabella Sperduti, Francesco Cognetti, Carmine M Carapella Journal of Experimental & Clinical Cancer Research 2011, 30:10 (18 January 2011) Abstract \| Full text \| PDF \| PubMed \| Cited on BioMed Central
	8.	Research Implementation of a new cost efficacy method for blood irradiation using a non dedicated device Paola Pinnarò, Antonella Soriani, Daniela D'Alessio, Carolina Giordano, Maria Foddai, Valentina Pinzi, Lidia Strigari Journal of Experimental & Clinical Cancer Research 2011, 30:7 (12 January 2011) Abstract \| Full text \| PDF \| PubMed
	9.	Research Preclinical evaluation of KIT/PDGFRA and mTOR inhibitors in gastrointestinal stromal tumors using small animal FDG PET Maria Pantaleo, Giordano Nicoletti, Cristina Nanni, Chiara Gnocchi, Lorena Landuzzi, Carmelo Quarta, Stefano Boschi, Margherita Nannini, Monica Di Battista, Paolo Castellucci, Stefano Fanti, Pier Lollini, Elena Bellan, Mauro Castelli, Domenico Rubello, Guido Biasco Journal of Experimental & Clinical Cancer Research 2010, 29:173 (30 December 2010) Abstract \| Full text \| PDF \| PubMed
	10.	Research Science, institutional archives and open access: an overview and a pilot survey on the Italian cancer research institutions Elisabetta Poltronieri, Ivana Truccolo, Corrado Di Benedetto, Mauro Castelli, Mauro Mazzocut, Gaetana Cognetti Journal of Experimental & Clinical Cancer Research 2010, 29:168 (20 December 2010) Abstract \| Full text \| PDF \| PubMed \| Cited on BioMed Central
	11.	Research Incidence of high chromogranin A serum levels in patients with non metastatic prostate adenocarcinoma Marialuisa Appetecchia, Aurela Meçule, Giuseppe Pasimeni, Concetta V Iannucci, Piero De Carli, Roberto Baldelli, Agnese Barnabei, Giovanni Cigliana, Isabella Sperduti, Michele Gallucci Journal of Experimental & Clinical Cancer Research 2010, 29:166 (17 December 2010) Abstract \| Full text \| PDF \| PubMed
	12.	Research *Chromogenic in situ* hybridization to detect EGFR gene copy number in cell blocks from fine-needle aspirates of non small cell lung carcinomas and lung metastases from colo-rectal cancer** Giovanni Simone, Anita Mangia, Andrea Malfettone, Vincenza Rubini, Michele Siciliano, Anna Di Benedetto, Irene Terrenato, Flavia Novelli, Marcella Mottolese Journal of Experimental & Clinical Cancer Research 2010, 29:125 (15 September 2010) Abstract \| Full text \| PDF \| PubMed
	13.	Research Immunohistochemical evaluation of inflammatory and proliferative markers in adjacent normal thyroid tissue in patients undergoing total thyroidectomy: results of a preliminary study Guglielmo Ardito, Luca Revelli, Alma Boninsegna, Alessandro Sgambato, Francesca Moschella, Maria Marzola, Erica Giustozzi, Nicola Avenia, Mauro Castelli, Domenico Rubello Journal of Experimental & Clinical Cancer Research 2010, 29:77 (17 June 2010) Abstract \| Full text \| PDF \| PubMed
	14.	Research Multi-detector row computed tomography (MDCT) and magnetic resonance imaging (MRI) in the evaluation of the mandibular invasion by squamous cell carcinomas (SCC) of the oral cavity. Correlation with pathological data Antonello Vidiri, Antonino Guerrisi, Raul Pellini, Valentina Manciocco, Renato Covello, Oreste Mattioni, Isabella Guerrisi, Salvatore Di Giovanni, Giuseppe Spriano, Marcello Crecco Journal of Experimental & Clinical Cancer Research 2010, 29:73 (17 June 2010) Abstract \| Full text \| PDF \| PubMed
	15.	Research Magnitude of benefit of the addition of bevacizumab to first-line chemotherapy for metastatic colorectal cancer: meta-analysis of randomized clinical trials Fotios Loupakis, Emilio Bria, Vanja Vaccaro, Federica Cuppone, Michele Milella, Paolo Carlini, Chiara Cremolini, Lisa Salvatore, Alfredo Falcone, Paola Muti, Isabella Sperduti, Diana Giannarelli, Francesco Cognetti Journal of Experimental & Clinical Cancer Research 2010, 29:58 (26 May 2010) Abstract \| Full text \| PDF \| PubMed
	16.	Review Proton pump inhibitors as anti vacuolar-ATPases drugs: a novel anticancer strategy Enrico P Spugnini, Gennaro Citro, Stefano Fais Journal of Experimental & Clinical Cancer Research 2010, 29:44 (8 May 2010) Abstract \| Full text \| PDF \| PubMed \| Cited on BioMed Central
	17.	Research Epithelioma of Malherbe: new ultrasound patterns Francesco M Solivetti, Fulvia Elia, Alessandra Drusco, Chiara Panetta, Ada Amantea, Aldo Di Carlo Journal of Experimental & Clinical Cancer Research 2010, 29:42 (6 May 2010) Abstract \| Full text \| PDF \| PubMed
	18.	Review Somatostatin analogues in the treatment of gastroenteropancreatic neuroendocrine tumours, current aspects and new perspectives Marialuisa Appetecchia, Roberto Baldelli Journal of Experimental & Clinical Cancer Research 2010, 29:19 (2 March 2010) Abstract \| Full text \| PDF \| PubMed
	19.	Research Subjective versus objective risk in genetic counseling for hereditary breast and/or ovarian cancers Anita Caruso, Cristina Vigna, Bruna Marozzo, Fabio M Sega, Isabella Sperduti, Francesco Cognetti, Antonella Savarese Journal of Experimental & Clinical Cancer Research 2009, 28:157 (21 December 2009) Abstract \| Full text \| PDF \| PubMed \| Editor’s summary Individuals with fewer relatives affected by breast and/or ovarian cancer than the common threshold for receiving genetic counseling overestimate their risk of developing the disease, highlighting the importance of wider access to genetic counseling.
	20.	Research The synthetic inhibitor of Fibroblast Growth Factor Receptor PD166866 controls negatively the growth of tumor cells in culture Gianfranco Risuleo, Marina Ciacciarelli, Mauro Castelli, Gaspare Galati Journal of Experimental & Clinical Cancer Research 2009, 28:151 (11 December 2009) Abstract \| Full text \| PDF \| PubMed
	21.	Review Urinary estrogen metabolites and prostate cancer: a case-control study and meta-analysis Maddalena Barba, Li Yang, Holger J Schünemann, Francesca Sperati, Sara Grioni, Saverio Stranges, Kim C Westerlind, Giovanni Blandino, Michele Gallucci, Rossella Lauria, Luca Malorni, Paola Muti Journal of Experimental & Clinical Cancer Research 2009, 28:135 (8 October 2009) Abstract \| Full text \| PDF \| PubMed
	22.	Case study Sexual dysfunction following surgery for rectal cancer - a clinical and neurophysiological study Alberto Pietrangeli, Patrizia Pugliese, Maria Perrone, Isabella Sperduti, Maurizio Cosimelli, Bruno Jandolo Journal of Experimental & Clinical Cancer Research 2009, 28:128 (17 September 2009) Abstract \| Full text \| PDF \| PubMed
	23.	Research Modeling of α/β for late rectal toxicity from a randomized phase II study: conventional versus hypofractionated scheme for localized prostate cancer Simona Marzi, Biancamaria Saracino, Maria G Petrongari, Stefano Arcangeli, Sara Gomellini, Giorgio Arcangeli, Marcello Benassi, Valeria Landoni Journal of Experimental & Clinical Cancer Research 2009, 28:117 (19 August 2009) Abstract \| Full text \| PDF \| PubMed
	24.	Review Adjuvant electrochemotherapy in veterinary patients: a model for the planning of future therapies in humans Enrico P Spugnini, Gennaro Citro, Alfonso Baldi Journal of Experimental & Clinical Cancer Research 2009, 28:114 (14 August 2009) Abstract \| Full text \| PDF \| PubMed \| Cited on BioMed Central
	25.	Research Resveratrol exhibits a strong cytotoxic activity in cultured cells and has an antiviral action against polyomavirus: potential clinical use Valerio Berardi, Francesca Ricci, Mauro Castelli, Gaspare Galati, Gianfranco Risuleo Journal of Experimental & Clinical Cancer Research 2009, 28:96 (1 July 2009) Abstract \| Full text \| PDF \| PubMed \| Editor’s summary Resveratrol, a naturally occurring antibiotic found in grape species used for red wine production, may prevent viral proliferation by inhibiting viral DNA production.